Cardiovascular Physiological Phenomena Clinical Trial
Official title:
The Impact of Fish-oil Fatty Acids on Postprandial Vascular Reactivity
The primary aim of this study is to determine the impact of individual fish oil fatty acids on vascular reactivity and to identify underlying physiological and molecular mechanism of any observed effects. In addition response to intervention according to genotype will be determined retrospectively.
A loss of vascular reactivity and increased vascular tone is being increasingly recognised
as a significant cardiovascular disease (CVD) risk factor and highly predictive of future
CVD events. A previous study by our group has shown the inclusion of a fish oil mixture
administered alongside a high fat meal preserves postprandial vascular function in healthy
men [1]. In this three arm, placebo controlled cross over study, the impact of individual
fatty acids contained within fish-oil on postprandial vascular reactivity (measured at 4
hour post test meal) will be assessed for the first time. Clinical measurements of vascular
function which correlate with CVD risk factors and are predictive of future CVD events will
be undertaken in order to assess any potentially beneficial effects. In addition plasma
samples will be taken at 0 and 4 hours to determine the change in concentration of
modulators of vascular tone. Accordingly, our nutrients of interest which will be
administered in the intervention arms of the study, will be present in this lipoprotein rich
fraction. By exposing cells in culture to these EPA- and DHA-enriched lipoproteins,
mechanisms underlying the vascular response in our human volunteers will be investigated.
Finally we will measure the plasma fatty acid profile to confirm that circulating
concentrations of EPA and DHA are increasing postprandially according to intake.
As it is now recognised that genetic variation, in addition to being an important
determinant of the risk of all known chronic diseases, plays a large part in determining an
individual's response to dietary change, DNA will be extracted from whole blood taken at the
clinical screening and stored for subsequent genotyping for variants likely to be important
in the regulation of EPA and DHA metabolism and vascular tone. Although the current study
will not be fully powered to generate definite conclusion regarding genotype*diet
interactions, it will serve to generate pilot data for future studies.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04242485 -
Osteopathy Treatment and Cardiovascular Recovery After a Rugby Match
|
N/A | |
Completed |
NCT01708356 -
Cycling, Air Pollution and Health
|
N/A | |
Not yet recruiting |
NCT06422481 -
Echocardiographic Measurement of Myocardial Work
|
N/A | |
Terminated |
NCT03397966 -
Metabolic Effects of Natriuretic Peptide Hormones
|
Phase 4 | |
Completed |
NCT03273803 -
Cardiac Auscultation Using Smartphones
|
N/A |